Susan Hasty, Publisher
Table of Contents . . . July 8th, 2002Non-Subscriber - Summaries Only
AIDS and HIV Pathogenesis - HIV targets virus-specific CD4 cells
Clinical Trials - Minority and HMO-insured patients poorly represented in HIV drug trials
AIDS and HIV Therapy - Line probe assay can predict treatment outcome
AIDS and HIV Therapy - Lopinavir can enhance safety, efficacy of antiretroviral regimens
AIDS Therapy - Researchers develop HIV fighter
AIDS and HIV Pathogenesis - Mucosal antibodies offer no protection
Antiretroviral Therapy - ViroLogic launches viral fitness assay for HIV patient testing
Correction - AIDS Weekly May 27, 2002, Headline Error
Restructuring - Novirio becomes Idenix Pharmaceuticals, Inc.
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.